Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

84 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of the beneficial effects of a GABA-based product containing Melissa officinalis on post-inflammatory irritable bowel syndrome: a preclinical study.
Lucarini E, Benvenuti L, Di Salvo C, D'Antongiovanni V, Pellegrini C, Valdiserra G, Ciampi C, Antonioli L, Lambiase C, Cancelli L, Grosso A, Di Cesare Mannelli L, Bellini M, Ghelardini C, Fornai M. Lucarini E, et al. Among authors: di salvo c. Front Pharmacol. 2024 Sep 20;15:1466824. doi: 10.3389/fphar.2024.1466824. eCollection 2024. Front Pharmacol. 2024. PMID: 39372212 Free PMC article.
Preclinical Development of FA5, a Novel AMP-Activated Protein Kinase (AMPK) Activator as an Innovative Drug for the Management of Bowel Inflammation.
Antonioli L, Pellegrini C, Fornai M, Benvenuti L, D'Antongiovanni V, Colucci R, Bertani L, Di Salvo C, Semeghini G, La Motta C, Giusti L, Zallocco L, Ronci M, Quattrini L, Angelucci F, Coviello V, Oh WK, Ha QTK, Németh ZH, Haskó G, Blandizzi C. Antonioli L, et al. Among authors: di salvo c. Int J Mol Sci. 2021 Jun 13;22(12):6325. doi: 10.3390/ijms22126325. Int J Mol Sci. 2021. PMID: 34199160 Free PMC article.
Palmitoylethanolamide Counteracts Enteric Inflammation and Bowel Motor Dysfunctions in a Mouse Model of Alzheimer's Disease.
D'Antongiovanni V, Pellegrini C, Antonioli L, Benvenuti L, Di Salvo C, Flori L, Piccarducci R, Daniele S, Martelli A, Calderone V, Martini C, Fornai M. D'Antongiovanni V, et al. Among authors: di salvo c. Front Pharmacol. 2021 Sep 29;12:748021. doi: 10.3389/fphar.2021.748021. eCollection 2021. Front Pharmacol. 2021. PMID: 34658885 Free PMC article.
Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology.
Pellegrini C, D'Antongiovanni V, Miraglia F, Rota L, Benvenuti L, Di Salvo C, Testa G, Capsoni S, Carta G, Antonioli L, Cattaneo A, Blandizzi C, Colla E, Fornai M. Pellegrini C, et al. Among authors: di salvo c. NPJ Parkinsons Dis. 2022 Jan 12;8(1):9. doi: 10.1038/s41531-021-00263-x. NPJ Parkinsons Dis. 2022. PMID: 35022395 Free PMC article.
Anti-inflammatory Effects of Novel P2X4 Receptor Antagonists, NC-2600 and NP-1815-PX, in a Murine Model of Colitis.
D'Antongiovanni V, Pellegrini C, Benvenuti L, Fornai M, Di Salvo C, Natale G, Ryskalin L, Bertani L, Lucarini E, Di Cesare Mannelli L, Ghelardini C, Nemeth ZH, Haskó G, Antonioli L. D'Antongiovanni V, et al. Among authors: di cesare mannelli l, di salvo c. Inflammation. 2022 Aug;45(4):1829-1847. doi: 10.1007/s10753-022-01663-8. Epub 2022 Mar 26. Inflammation. 2022. Retraction in: Inflammation. 2024 Sep 14. doi: 10.1007/s10753-024-02143-x PMID: 35338432 Free PMC article. Retracted.
The administration of Enterococcus faecium SF68 counteracts compositional shifts in the gut microbiota of diet-induced obese mice.
Panattoni A, Calvigioni M, Benvenuti L, D'Antongiovanni V, Pellegrini C, Di Salvo C, Mazzantini D, Celandroni F, Fornai M, Antonioli L, Ghelardi E. Panattoni A, et al. Among authors: di salvo c. Front Microbiol. 2022 Dec 16;13:1054097. doi: 10.3389/fmicb.2022.1054097. eCollection 2022. Front Microbiol. 2022. PMID: 36590404 Free PMC article.
Dietary Supplementation with the Probiotic SF68 Reinforces Intestinal Epithelial Barrier in Obese Mice by Improving Butyrate Bioavailability.
Benvenuti L, D'Antongiovanni V, Pellegrini C, Fornai M, Bernardini N, Ippolito C, Segnani C, Di Salvo C, Colucci R, Martelli A, Flori L, Calderone V, Carta G, Ghelardi E, Calvigioni M, Panattoni A, Coppolecchia R, Arini A, Antonioli L. Benvenuti L, et al. Among authors: di salvo c. Mol Nutr Food Res. 2023 Jul;67(13):e2200442. doi: 10.1002/mnfr.202200442. Epub 2023 May 16. Mol Nutr Food Res. 2023. PMID: 37099449
Author Correction: Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology.
Pellegrini C, D'Antongiovanni V, Miraglia F, Rota L, Benvenuti L, Di Salvo C, Testa G, Capsoni S, Carta G, Antonioli L, Cattaneo A, Blandizzi C, Colla E, Fornai M. Pellegrini C, et al. Among authors: di salvo c. NPJ Parkinsons Dis. 2023 Jun 2;9(1):83. doi: 10.1038/s41531-023-00536-7. NPJ Parkinsons Dis. 2023. PMID: 37268652 Free PMC article. No abstract available.
Use of Saccharomyces boulardii CNCM I-745 as therapeutic strategy for prevention of nonsteroidal anti-inflammatory drug-induced intestinal injury.
D'Antongiovanni V, Antonioli L, Benvenuti L, Pellegrini C, Di Salvo C, Calvigioni M, Panattoni A, Ryskalin L, Natale G, Banni S, Carta G, Ghelardi E, Fornai M. D'Antongiovanni V, et al. Among authors: di salvo c. Br J Pharmacol. 2023 Dec;180(24):3215-3233. doi: 10.1111/bph.16200. Epub 2023 Aug 27. Br J Pharmacol. 2023. PMID: 37519261 Free article.
84 results